DIASORIN (Germany) Top Management
34D Stock | EUR 97.92 2.98 2.95% |
DIASORIN employs about 29 people. The company is managed by 20 executives with a total tenure of roughly 221 years, averaging almost 11.0 years of service per executive, having 1.45 employees per reported executive. Evaluation of DIASORIN's management performance can provide insight into the firm performance.
Carlo Rosa CEO Chief Executive Officer, Executive Director, General Manager |
Michele Denegri Chairman Non-Executive Deputy Chairman of the Board |
DIASORIN |
DIASORIN Management Team Effectiveness
DIASORIN's management efficiency ratios could be used to measure how well DIASORIN manages its routine affairs as well as how well it operates its assets and liabilities.DIASORIN Workforce Comparison
DIASORIN is number one stock in number of employees category among its peers. The total workforce of Other industry is presently estimated at about 20,564. DIASORIN adds roughly 29.0 in number of employees claiming only tiny portion of all equities under Other industry.
DIASORIN Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. DIASORIN Price Series Summation is a cross summation of DIASORIN price series and its benchmark/peer.
DIASORIN Notable Stakeholders
A DIASORIN stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DIASORIN often face trade-offs trying to please all of them. DIASORIN's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DIASORIN's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Carlo Rosa | Chief Executive Officer, Executive Director, General Manager | Profile | |
Michele Denegri | Non-Executive Deputy Chairman of the Board | Profile | |
Gustavo Denegri | Non-Executive Chairman of the Board | Profile | |
Stefano Ronchi | Senior Corporate Vice President - Human Resources | Profile | |
Chen Even | Senior Corporate Vice President - Commercial Operations and Executive Director | Profile | |
Piergiorgio Pedron | Senior Corporate VP and Chief Financial Officer | Profile | |
Francesca Pasinelli | Independent Director | Profile | |
Giancarlo Boschetti | Non-Executive Director | Profile | |
Tullia Todros | Independent Director | Profile | |
Riccardo Fava | External Relations Director, Head of Investor Relations and Media | Profile | |
Giuseppe Alessandria | Lead Independent Director | Profile | |
Roberta Somati | Independent Director | Profile | |
Stefano Altara | Non-Executive Director | Profile | |
Franco Moscetti | Independent Director | Profile | |
Fiorella Altruda | Independent Director | Profile | |
Monica Tardivo | Independent Director | Profile | |
Elisa Corghi | Independent Director | Profile | |
John Gerace | President DiaSorin Molecular LLC | Profile | |
Luca Melindo | Non-Executive Director | Profile | |
Ugo Gay | Senior Corporate Vice President - Industrial Operations | Profile |
About DIASORIN Management Performance
The success or failure of an entity such as DIASORIN often depends on how effective the management is. DIASORIN management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DIASORIN management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DIASORIN management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of DIASORIN's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DIASORIN's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of DIASORIN's management manipulating its earnings.
DIASORIN Workforce Analysis
Traditionally, organizations such as DIASORIN use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DIASORIN within its industry.DIASORIN Manpower Efficiency
Return on DIASORIN Manpower
Revenue Per Employee | 42.7M | |
Revenue Per Executive | 61.9M | |
Net Income Per Employee | 10.7M | |
Net Income Per Executive | 15.5M |
Complementary Tools for DIASORIN Stock analysis
When running DIASORIN's price analysis, check to measure DIASORIN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIASORIN is operating at the current time. Most of DIASORIN's value examination focuses on studying past and present price action to predict the probability of DIASORIN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIASORIN's price. Additionally, you may evaluate how the addition of DIASORIN to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |